Latham & Watkins is advising Rhythm Pharmaceuticals on the transaction, and Ropes & Gray is advising Perceptive Advisors LLC. Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (Rhythm), a commercial-stage...
You must be a Standard 1 Year member to access this content.
Homburger advised Addex Therapeutics Ltd., Advestra acted for Perceptive Advisors. Addex Therapeutics, a clinical-stage biopharmaceutical company, listed on the SIX Swiss Exchange and on the Nasdaq,...
You must be a Standard 1 Year member to access this content.
Proskauer advised Perceptive Advisors on the deal. Perceptive Advisors completed the first and final closing of Perceptive Xontogeny Venture Fund II, LP (“PXV Fund II”) with $515...
You must be a Standard 1 Year member to access this content.
